PolyPid Announces Top-line Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Surgery
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Nechama Feuerstein Bob Yedid Exchange Commission Company Annual Report On Form Drug Administration Polypid Ltd
Source: apnews.com